magnum, as usual thanks again for the info.
adamben, it does not take 8-12 yrs to get a new drug to market. average is around 5-6 yrs.
banarep, i also bought vertex stock when I was in the study. I bought it at $22, after a year I sold half of it and got inital investment back. I guess you can say at this point I doubled my money. Also waiting for Telap approval for stock to go through the roof ! I think even though stock is around $35 a share right now it is still a good buy. I see it going to at least $70 a share next year when approved by fda.
thanks for the info. after being in the vertex study, I am now a stock holder and can not wait for telaprevir to be made available.
I was supposed to be in that study, but apparently I'm meant to get into something else down the road. Just based on history, VX222, if as successful as expected, will most likely not be approved for 8-10 years or so. Look how long Telaprevir and Bocep are taking. They were expected out a few years ago and we're still waiting...
PS Meant tela and 222 which personally if I had had a chance I would have loved to do rather than 72 weeks.
Thank you Magnum - disappointing but not surprising, i think we are used to this story by now.